Patent US4968616A successfully refreshed from Google Patents.
US4968616A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Superoxide dismutase derivatives, method of producing same and medicinal use of same
Assignee: INOUE MASAYASU 3-49-3 IKEDA KUMAMOTO CITY KUMAMOTO JAPAN
•
Filing: 1987-05-13
•
Granted: 1990-11-06
•
Expires: 2007-05-13
Abstract
Abstract Novel superoxide dismutase derivatives are provided in which the enzymatic activity of superoxide dismutase capable of decomposing superoxide, a substance harmful to living organisms, is for the most part maintained with the plasma half-life being significantly prolonged as compared with superoxide dismutase itself. They have pharmacological activities such as anti-inflammatory, anti-ischemic and cerebral edema-preventing activities. Also provided are a method of producing such superoxide dismutase derivatives and medicinal uses of them.
Inventors
- 👤 Masayasu Inoue
- 👤 Tetsuya Ogino
- 👤 Yoshimasa Morino
- 👤 Masahiko Hirota
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 20:18
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/0004; C12N9/0065; A; A61; A61K; A61K38/00; A61K38/16; A61K38/43; A61K38/44; A61K38/446; A61K47/00; A61K47/50; A61K47/51; A61K47/56; A61K47/58; C12N11/00; C12N11/02; C12N11/08; C12N11/082
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
144 words
A superoxide dismutase derivative of the formula (SOD) (Z).sub.x wherein (SOD) is a superoxide dismutase residue having 1 to 6 groups each derived from an amino group by removal of one hydrogen atom, (Z) is a monovalent copolymer residue comprising the following three units: (a) a unit having the formula: ##STR9## (b) a unit having the formula: ##STR10## in which R 7 is a hydrogen atom or a butyl group, and (c) a unit having the formula: ##STR11## in which the carbonyl carbon atom of unit (c) is bound to (SOD) via a nitrogen atom of an amino group of (SOD), the copolymer residue having a weight-average molecular weight of 800 to 20,000, and x is an integer of 1 to 6 which corresponds to the number of the groups of (SOD) each derived from an amino group by removal of one hydrogen atom.
Claim 2
Dependent Claim
144 words
A superoxide dismutase derivative of the formula (SOD) (Z).sub.x wherein (SOD) is a superoxide dismutase residue having 1 to 6 groups each derived from an amino group by removal of one hydrogen atom, (Z) is a monovalent copolymer residue comprising the following three units: (a) a unit having the formula: ##STR9## (b) a unit having the formula: ##STR10## in which R 7 is a hydrogen atom or a butyl group, and (c) a unit having the formula: ##STR11## in which the carbonyl carbon atom of unit (c) is bound to (SOD) via a nitrogen atom of an amino group of (SOD), the copolymer residue having a weight-average molecular weight of 800 to 20,000, and x is an integer of 1 to 6 which corresponds to the number of the groups of (SOD) each derived from an amino group by removal of one hydrogen atom.
Claim 3
Dependent Claim
39 words
The superoxide dismutase derivative of claim 1 wherein the mole ratio of the constituent unit (a) to the constituent units (b) and (c), i.e. (a)/{(b)+(c)}, in the copolymer is substantially within the range of about 1 to about 1.3.
Claim 4
Independent Claim
217 words
A method of producing a superoxide dismutase derivative of the formula (SOD) (Z).sub.x wherein (SOD) is a superoxide dismutase residue having 1 to 6 groups each derived from an amino group by removal of one hydrogen atom, (Z) is a monovalent copolymer residue comprising the following three units: (a) a unit having the formula: ##STR12## (b) a unit having the formula: ##STR13## in which R 7 is a hydrogen atom or a butyl group, and (c) a unit having the formula: ##STR14## in which the carbonyl carbon atom of unit (c) is bound to (SOD) via a nitrogen atom of an amino group of (SOD), the copolymer residue having a weight-average molecular weight of 800 to 20,000, and x is an integer of 1 to 6 which corresponds to the number of the groups of (SOD) each derived from an amino group by removal of one hydrogen atom, which comprises reacting superoxide dismutase with a copolymer comprising the following three units: (a) a unit having the formula: ##STR15## (b) a unit having the formula: ##STR16## in which R 7 is a hydrogen atom or a butyl group, and (c) a unit having the formula: ##STR17## and having a weight-average molecular weight of 800 to 20,000, in an aqueous alkaline solution having a pH of 7 to 11.
Claim 5
Independent Claim
217 words
A method of producing a superoxide dismutase derivative of the formula (SOD) (Z).sub.x wherein (SOD) is a superoxide dismutase residue having 1 to 6 groups each derived from an amino group by removal of one hydrogen atom, (Z) is a monovalent copolymer residue comprising the following three units: (a) a unit having the formula: ##STR12## (b) a unit having the formula: ##STR13## in which R 7 is a hydrogen atom or a butyl group, and (c) a unit having the formula: ##STR14## in which the carbonyl carbon atom of unit (c) is bound to (SOD) via a nitrogen atom of an amino group of (SOD), the copolymer residue having a weight-average molecular weight of 800 to 20,000, and x is an integer of 1 to 6 which corresponds to the number of the groups of (SOD) each derived from an amino group by removal of one hydrogen atom, which comprises reacting superoxide dismutase with a copolymer comprising the following three units: (a) a unit having the formula: ##STR15## (b) a unit having the formula: ##STR16## in which R 7 is a hydrogen atom or a butyl group, and (c) a unit having the formula: ##STR17## and having a weight-average molecular weight of 800 to 20,000, in an aqueous alkaline solution having a pH of 7 to 11.
Claim 6
Dependent Claim
17 words
The method of claim 1, wherein the superoxide dismutase is human superoxide dismutase or bovine superoxide dismutase.
Claim 7
Dependent Claim
21 words
The method of claim 3, wherein the human or bovine superoxide dismutase is a superoxide dismutase produced by genetic engineering techniques.
Claim 8
Dependent Claim
19 words
The method of claim 1, wherein the superoxide dismutase is human erythrocyte superoxide dismutase or bovine erythrocyte superoxide dismutase.
Claim 9
Dependent Claim
43 words
The method of producing a superoxide dismutase derivative of claim 1, where the mole ratio of the constituent unit (a) to the constituent units (b) and (c), i.e. (a)/{(b)+(c)}, in the copolymer is substantially within the range of about 1 to about 1.3.
Claim 10
Dependent Claim
25 words
The method of claim 1, wherein the copolymer is used in an amount of about 0.5 to about 30 moles per mole of superoxide dismutase.
Claim 11
Dependent Claim
25 words
The method of claim 1, wherein the aqueous alkaline solution is an aqueous solution of sodium carbonate, sodium hydrogen carbonate, sodium acetate or sodium phosphate.
Claim 12
Dependent Claim
23 words
The method of claim 1, wherein the reaction is carried out at a temperature of from about 3° C. to about 50° C.
Claim 13
Dependent Claim
172 words
A pharmaceutical composition for the prevention or treatment of an ischemic disease, said composition comprising an amount, effective for the prevention or treatment of an ischemic disease of a superoxide dismutase derivative of the formula (SOD) (Z).sub.x wherein (SOD) is a superoxide dismutase residue having 1 to 6 groups each derived from an amino group by removal of one hydrogen atom, (Z) is a monovalent copolymer residue comprising the following three units: (a) a unit having the formula: ##STR18## (b) a unit having the formula: ##STR19## in which R 7 is a hydrogen atom or a butyl group, and (c) a unit having the formula: ##STR20## in which the carbonyl carbon atom of unit (c) is bound to (SOD) via a nitrogen atom of an amino group of (SOD), the copolymer residue having a weight-average molecular weight of 800 to 20,000, and x is an integer of 1 to 6 which corresponds to the number of the groups of (SOD) each derived from an amino group by removal of one hydrogen atom.
Claim 14
Dependent Claim
172 words
A pharmaceutical composition for the prevention or treatment of an ischemic disease, said composition comprising an amount, effective for the prevention or treatment of an ischemic disease of a superoxide dismutase derivative of the formula (SOD) (Z).sub.x wherein (SOD) is a superoxide dismutase residue having 1 to 6 groups each derived from an amino group by removal of one hydrogen atom, (Z) is a monovalent copolymer residue comprising the following three units: (a) a unit having the formula: ##STR18## (b) a unit having the formula: ##STR19## in which R 7 is a hydrogen atom or a butyl group, and (c) a unit having the formula: ##STR20## in which the carbonyl carbon atom of unit (c) is bound to (SOD) via a nitrogen atom of an amino group of (SOD), the copolymer residue having a weight-average molecular weight of 800 to 20,000, and x is an integer of 1 to 6 which corresponds to the number of the groups of (SOD) each derived from an amino group by removal of one hydrogen atom.
Claim 15
Dependent Claim
38 words
The pharmaceutical composition of claim 20 where the mole ratio of the constituent unit (a) to the constituent units (b) and (c), i.e. (a)/{(b)+(c)}, in the copolymer is substantially within the range of about 1 to about 1.3.
Claim 16
Independent Claim
169 words
A method of preventing or treating an ischemic disease which comprises administering an effective amount for the prevention or treatment of an ischemic disease of a superoxide dismutase derivative of the formula (SOD) (Z).sub.x wherein (SOD) is a superoxide dismutase residue having 1 to 6 groups each derived from an amino group by removal of one hydrogen atom, (Z) is a monovalent copolymer residue comprising the following three units: (a) a unit having the formula: ##STR21## (b) a unit having the formula: ##STR22## in which R 7 is a hydrogen atom or a butyl group, and (c) a unit having the formula: ##STR23## in which the carbonyl carbon atom of unit (c) is bound to (SOD) via a nitrogen atom of an amino group of (SOD), the copolymer residue having a weight-average molecular weight of 800 to 20,000, and x is an integer of 1 to 6 which corresponds to the number of the groups of (SOD) each derived from an amino group by removal of one hydrogen atom.
Claim 17
Independent Claim
169 words
A method of preventing or treating an ischemic disease which comprises administering an effective amount for the prevention or treatment of an ischemic disease of a superoxide dismutase derivative of the formula (SOD) (Z).sub.x wherein (SOD) is a superoxide dismutase residue having 1 to 6 groups each derived from an amino group by removal of one hydrogen atom, (Z) is a monovalent copolymer residue comprising the following three units: (a) a unit having the formula: ##STR21## (b) a unit having the formula: ##STR22## in which R 7 is a hydrogen atom or a butyl group, and (c) a unit having the formula: ##STR23## in which the carbonyl carbon atom of unit (c) is bound to (SOD) via a nitrogen atom of an amino group of (SOD), the copolymer residue having a weight-average molecular weight of 800 to 20,000, and x is an integer of 1 to 6 which corresponds to the number of the groups of (SOD) each derived from an amino group by removal of one hydrogen atom.
Claim 18
Dependent Claim
37 words
The method of claim 13 where the mole ratio of the constituent unit (a) to the constituent units (b) and (c), i.e. (a)/{(b)+(c)}, in the copolymer is substantially within the range of about 1 to about 1.3.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-11-05 | 1994-05-07 | 1994-11-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-11-05 | 1998-05-07 | 1998-11-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-11-05 | 2002-05-07 | 2002-11-06 | $7700.00 | Window Closed / Lapsed |